Bioactive Lipids as Mediators of the Beneficial Actions of Statins.
Sign Up to like & getrecommendations! Published in 2019 at "Journal of Cardiovascular Pharmacology"
DOI: 10.1097/fjc.0000000000000689
Abstract: Atorvastatin, a 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitor, is known to be of significant benefit in the treatment of hyperlipidemias. In addition, statins have the ability to attenuate matrix metalloprotease activity, reduce inflammatory response, restore… read more here.
Keywords: beneficial actions; actions statins; action doxorubicin; cancer ... See more keywords